Skip to main content
. 2017 Oct 25;17:112. doi: 10.1186/s12876-017-0668-8

Fig. 7.

Fig. 7

Cumulative survival rate of PVT. Cumulative survival rate for all patients (a), and according to the type of liver cirrhosis (b), response to treatment with danaparoid sodium (CR: complete response, PR: partial response, NC: no response) (c), and for patients with and without hepatocellular carcinoma (HCC) (d)